News

With strong hedge fund interest and a low price-to-earnings ratio, Pfizer Inc. (NYSE:PFE) secures a place on our list of the ...
Discover key highlights in healthcare stocks, including UnitedHealth's surge after a Buffett stake, Eli Lilly lawsuits, Trump pharma tariffs & Bayer's ...
Pfizer Inc. and Astellas Pharma Inc. have announced positive topline results from the Phase 3 EV-303 clinical trial (also ...
Beam Therapeutics' base editing technology shows early promise in sickle cell and AATD, but commercial success is years away ...
The landscape of COVID-19 vaccinations for children is shifting in the US. How will this affect the upcoming virus season?